Katja Rohwedder
-
- Diabetes Treatment and Management 21
- Hormonal Regulation and Hypertension 13
- Diabetes Management and Research 7
- Pharmacology top 5%
- Surgery top 5%
- Pancreatic function and diabetes 9
- Nephrology top 10%
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer 12
-
- Heart Failure Treatment and Management 6
- Blood Pressure and Hypertension Studies 3
- Cardiovascular Function and Risk Factors 3
- Co-authors
- Shamik ParikhStefano Del PratoMichael A. NauckS. Durán‐GarcíaJennifer SuggM. ElzeJuris J. MeierVincent Woo
- Journals
- Circulation (1 paper)Annals of Internal Medicine (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Katja Rohwedder
24 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 1.2k
- Pharmacology 275
- Surgery 577
- Nephrology 77
- Molecular Biology 698
Countries citing papers authored by Katja Rohwedder
This map shows the geographic impact of Katja Rohwedder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Rohwedder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Rohwedder more than expected).
Fields of papers citing papers by Katja Rohwedder
This network shows the impact of papers produced by Katja Rohwedder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Rohwedder. The network helps show where Katja Rohwedder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katja Rohwedder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 9 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 19 | |
| 14 | 2020 | 33 | |
| 15 | 2018 | 10 | |
| 16 | 2014 | 1 | |
| 17 | 2013 | 9 | |
| 18 | 2013 | 6 | |
| 19 | Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin | 2012 | 25 |
| 20 | Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metforminbreakdown → | 2011 | 427 |
About Katja Rohwedder
Katja Rohwedder is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (21 papers), Hormonal Regulation and Hypertension (13 papers), Metabolism, Diabetes, and Cancer (12 papers), Pancreatic function and diabetes (9 papers), Diabetes Management and Research (7 papers), Heart Failure Treatment and Management (6 papers), Blood Pressure and Hypertension Studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Pharmacology (275 citations) and Surgery (577 citations). Katja Rohwedder has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Shamik Parikh, Stefano Del Prato, Michael A. Nauck, S. Durán‐García, Jennifer Sugg, M. Elze, Juris J. Meier, Vincent Woo, John Wilding and Keith Bowering. Their work appears in journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.